Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:00 PM
Ignite Modification Date:
2025-12-24 @ 8:00 PM
NCT ID:
NCT06617104
Eligibility Criteria:
Inclusion Criteria:
1. Disease group：
* Diagnosed with schizophrenia by a physician (ICD-10 code F20, such as F20.0, F20.1, F20.2, F20.3, F20.5, F20.89, or F20.9), with stable condition, and has not had any changes in medication dosage or admission to a psychiatric acute care unit in the past 3 months.
* Aged between 18 and 65 years.
* Able to understand, speak, read, and write Mandarin or Taiwanese.
2. Control group：
* No history of chronic illness and no acute symptoms within the past month.
* Aged between 18 and 65 years.
* Able to understand, speak, read, and write Mandarin or Taiwanese.
Exclusion Criteria:
1. Disease group：
* Individuals with cardiovascular conditions, severe neurological disorders (e.g., organic brain disorders, early-stage dementia or diagnosed dementia), or substance abuse issues.
* Individuals who have used medications affecting the autonomic nervous system within the past month, such as mood stabilizers, antidepressants, angiotensin-converting enzyme inhibitors inhibitors, β-blockers, or antiarrhythmics.
* Individuals with metallic implants that could affect heart rate variability.
* Individuals with involuntary and uncontrollable body tremors.
* Women currently menstruating.
* Pregnant women.
2. Control group：
* Individuals with cardiovascular conditions, severe neurological disorders (e.g., organic brain disorders, early-stage dementia or diagnosed dementia), or substance abuse issues.
* Individuals who have used medications affecting the autonomic nervous system within the past month, such as psychiatric medications, angiotensin-converting enzyme inhibitors inhibitors, β-blockers, or antiarrhythmics .
* Individuals with metallic implants that could affect heart rate variability.
* Individuals with involuntary and uncontrollable body tremors.
* Women currently menstruating.
* Pregnant women.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06617104
Study Brief:
Protocol Section:
NCT06617104